Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA strange or metallic taste after a Wegovy injection is real, documented, and far more common than most people expect. Reported in semaglutide trial data and consistent with how GLP-1 medicines alter gastric and oral sensation, the taste usually appears within hours of injecting and fades on its own. It is not a sign that something has gone wrong. If you have just noticed it for the first time and are quietly wondering whether to be worried, the short answer is: you almost certainly do not need to be. That said, understanding what is behind it helps you know what to watch and when to act. The NHS medicines page for semaglutide lists taste disturbance among the known side effects of this class of drug, and the guidance is consistent: most mild oral symptoms settle as your body adjusts to the medicine. Because Wegovy is a prescription-only medicine, any concern that persists or sits alongside other symptoms should go to your prescriber rather than a search engine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP clinical programme that supported Wegovy's approval enrolled thousands of adults and tracked adverse events closely. Taste disturbance, sometimes reported as a metallic, sour or simply "off" flavour, appeared in the semaglutide groups at a higher rate than placebo. The effect is consistent across GLP-1 medicines as a class and is considered a known, if underreported, part of the GI side-effect profile. The STEP 1 trial, published in the New England Journal of Medicine, showed that gastrointestinal events were the most common reason participants paused or adjusted their dose, taste changes sit within that broader GI picture rather than as an isolated oddity.
The mechanism is not fully pinned down, but researchers point to two overlapping pathways. First, semaglutide slows the rate at which food and stomach contents move through the gut. Slower gastric emptying alters the pressure, gas and acid balance in the upper digestive tract, and that can affect what flavour signals reach the back of the throat and palate. Second, GLP-1 receptors exist in the brain and peripheral nervous system, not just the gut, and there is emerging evidence that they influence taste perception more directly. Either way, the result is the same experience: something tastes faintly wrong for a while after your injection day.
Timing matters here. If you have ever wondered whether you can taste Wegovy after injection, most people notice the funny taste within a few hours of injecting and find it has cleared by the following day. A smaller number carry a mild taste disturbance for two or three days around each dose. Both patterns are within the expected range.
Wegovy's well-established side-effect profile is dominated by GI symptoms: nausea, constipation, loose stools, indigestion and burping are the ones most commonly flagged in clinical guidance. Taste change does not usually appear at the top of that list, which is partly why people find it surprising when it happens to them. It can feel more unsettling than nausea, simply because it is less expected.
The pattern is worth knowing. Symptoms tend to be most noticeable when you first start treatment, and again after each dose increase, because the body is adjusting to a higher level of drug activity. Once you have been stable on a maintenance dose for a few weeks, many people find the taste effect fades considerably. If you are also noticing tiredness after injecting, that follows a similar adjustment arc and usually improves with the same approach: staying hydrated, eating smaller meals and giving your system time.
There is a separate question about whether what you are tasting is actually the medicine itself (more on that in a moment) but the physiological side-effect pathway described above is the most common explanation. It is worth distinguishing it from injection-site issues, which are a different matter entirely; lumps or firmness at the injection site are unrelated to taste changes and have their own causes.
One thing our prescribers hear fairly regularly: people who notice a funny taste assume they have done something wrong. Injected into the wrong spot. Let the pen warm up too long. Used a bent needle. In the vast majority of cases, none of those things caused the taste. It is the medicine doing what GLP-1 medicines do.
There is no clinical intervention specifically for semaglutide-related taste change, but several straightforward habits reduce how much it bothers people in practice. Staying well hydrated throughout injection day and the day after keeps the mouth from feeling stale or coated. Mild, neutral foods (plain crackers, rice, unseasoned vegetables) are easier to enjoy when your taste perception is slightly off, and they also help manage any accompanying nausea. Strong flavours like coffee, citrus or spicy food can feel amplified or unpleasant when the baseline is already shifted, so some people choose to avoid them around dose day.
Good mouth hygiene matters more than usual during this period. Brushing teeth and using a tongue scraper after meals removes residual food particles that can interact with an already-altered taste baseline. Some people find that a mild, alcohol-free mouth rinse helps; others prefer plain water. None of this treats the underlying mechanism, but it reduces the overlay of avoidable sensory noise. If you are using the Wegovy green pen, the device and injection process are the same regardless of which dose you are on, so any taste-related habits you build at one stage carry through to the next.
If cost is a factor in whether you continue treatment rather than stopping because of manageable side effects, it may be worth reading about how Wegovy pricing works in the UK before making any decisions, pausing treatment without clinical guidance can mean restarting titration from a lower dose.
The line to watch: if the taste is accompanied by severe, persistent stomach pain (especially pain that radiates toward the back) that is not a routine adjustment symptom. The MHRA issued a specific Drug Safety Update in January 2026 highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines, and severe stomach pain is the key warning sign. Seek urgent medical attention if that combination occurs. You can also report unexpected symptoms through the MHRA's Yellow Card scheme, which exists precisely to capture real-world experience with newer medicines like Wegovy.
A mild, transient funny taste does not require an urgent call. But your prescriber should know about it if it is significantly affecting your ability to eat, contributing to weight loss beyond what is expected, or persisting well beyond your usual injection-day window. Taste disturbance that makes food consistently unappealing can quietly tip into inadequate nutrition over weeks, which matters on a medicine that already reduces appetite.
Prescribers can offer practical guidance on timing, hydration and nutrition, and in some cases may review whether your current dose is the right one for your tolerance profile. Titration exists for exactly this reason: the dose schedule for Wegovy is designed to be adjusted to what your body can manage, not pushed past it. You can learn more about how Wegovy works as a treatment on our Wegovy overview page.
If you are not yet on treatment and are trying to understand what to expect before starting, or if you have been managing this side effect on your own and would benefit from a clinical conversation, speaking to our prescribers is a good next step. Every consultation at nume is reviewed by a GPhC-registered prescriber, not software, and our aftercare team is available seven days a week for exactly these kinds of questions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.